AMATO, Rosario
 Distribuzione geografica
Continente #
NA - Nord America 1.642
AS - Asia 884
EU - Europa 644
SA - Sud America 164
Continente sconosciuto - Info sul continente non disponibili 78
AF - Africa 21
OC - Oceania 3
Totale 3.436
Nazione #
US - Stati Uniti d'America 1.586
IT - Italia 377
SG - Singapore 375
CN - Cina 236
BR - Brasile 129
VN - Vietnam 85
DE - Germania 77
IN - India 70
SE - Svezia 44
GB - Regno Unito 43
CA - Canada 35
FI - Finlandia 34
BD - Bangladesh 32
HK - Hong Kong 24
NL - Olanda 19
IQ - Iraq 15
JP - Giappone 12
MX - Messico 12
AR - Argentina 11
ID - Indonesia 11
PL - Polonia 10
EC - Ecuador 9
ZA - Sudafrica 7
ES - Italia 6
FR - Francia 6
AT - Austria 5
CL - Cile 5
EU - Europa 5
CO - Colombia 4
RU - Federazione Russa 4
UA - Ucraina 4
CZ - Repubblica Ceca 3
EG - Egitto 3
PK - Pakistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
TR - Turchia 3
CR - Costa Rica 2
GT - Guatemala 2
HU - Ungheria 2
KE - Kenya 2
LT - Lituania 2
MA - Marocco 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
SC - Seychelles 2
TN - Tunisia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
IE - Irlanda 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PW - Palau 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.366
Città #
San Jose 237
Dallas 193
Chandler 167
Ashburn 144
Singapore 122
Santa Clara 74
Munich 62
Council Bluffs 58
Milan 53
Bengaluru 52
Beijing 51
Hefei 50
Catanzaro 39
Princeton 37
Ho Chi Minh City 36
Lawrence 36
London 32
Chicago 27
Turku 25
Hong Kong 24
Phoenix 24
Los Angeles 20
Wilmington 19
Des Moines 18
Seattle 18
New York 17
Rome 15
São Paulo 14
Hanoi 13
Ottawa 12
Tokyo 12
Naples 10
Norwalk 10
Toronto 10
Helsinki 8
Aversa 7
Florence 7
Mexico City 7
Shanghai 7
Assago 6
Baghdad 6
Boardman 6
Bologna 6
Buffalo 6
Genova 6
Guangzhou 6
Padua 6
Shenzhen 6
Warsaw 6
Chennai 5
Dhaka 5
Jakarta 5
Siena 5
Stockholm 5
Verdellino 5
Amsterdam 4
Atlanta 4
Brooklyn 4
Campi Salentina 4
Curitiba 4
Falls Church 4
Grottaglie 4
Guayaquil 4
Johannesburg 4
Orem 4
Redmond 4
Rende 4
Rio de Janeiro 4
San Francisco 4
Thái Nguyên 4
Turin 4
Al Mansurah 3
Bari 3
Brasília 3
Charlotte 3
Chittagong 3
Columbus 3
Frankfurt am Main 3
Genoa 3
Haiphong 3
Hanover 3
Lamezia Terme 3
Lurate Caccivio 3
Napoli 3
Nuremberg 3
Olomouc 3
San Giovanni in Fiore 3
Uberlândia 3
Vasto 3
Washington 3
Ankara 2
Araraquara 2
Arcene 2
Biên Hòa 2
Bogotá 2
Boston 2
Buenos Aires 2
Bình Dương 2
Campinas 2
Castrolibero 2
Totale 1.998
Nome #
Hereditary Transthyretin Amyloidosis: Genetic Characterization of the TTR P.Val142Ile Variant in a Calabrian Kindred 181
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells. 146
In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity 102
Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy 96
Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy. 96
Alternative splicing regulation in tumour cells of gene encoding the tyrosine phosphatase PTPRJ 93
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells. 85
A familial form of epidermolysis bullosa simplex associated with a pathogenic variant in krt5 84
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold 78
The human asparaginase enzyme (ASPG) inhibits growth in leukemic cells 77
Metabolic drives affecting Th17/Treg gene expression changes and differentiation: impact on immune‐microenvironment regulation 72
SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation 69
IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells 68
60kDa lysophospholipase, a new Sgk1 molecular partner involved in the regulation of ENaC 68
Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators 67
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells 66
SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation 66
Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation 66
Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition 65
RANBP1, a member of the nuclear-cytoplasmic trafficking-regulator complex, is the terminal-striking point of the SGK1-dependent Th17+ pathological differentiation 64
Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas. 64
Deregulation of SGK1 in Ulcerative Colitis: a paradoxical relationship between immune cells and colonic epithelial cells 63
RANBP1 (RAN Binding Protein 1): The Missing Genetic Piece in Cancer Pathophysiology and Other Complex Diseases 62
Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors 62
60 kDa Lysophospholipase, a New Sgk1 MolecularnPartner Involved in the Regulation of ENaC 61
Data on the effects of low iron diet on serum lipid profile in HCV transgenic mouse model 58
The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms 57
SGK1, the serum- and glucocorticoid-regulated kinase, modulates the response to taxanes by regulating the GTPase RAN and its partners in colon carcinoma cells. 56
RANBP1 regulates the SGK1-dependent Th17 pathological differentiation: nuclear export hypothesis 55
Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells. 55
Spatial-transcriptomic profiling: a new lens for understanding myelofibrosis pathophysiology 54
Identification of a new mutation in the gene coding for hairless protein responsible for alopecia universalis: The importance of direct gene sequencing 54
Kinase Inhibitors in Genetic Diseases 53
Pathophysiology of the insulin receptor signal transduction 53
The SGK1 Inhibitor SI113 Induces Autophagy, Apoptosis and Endoplasmic Reticulum Stress in Endometrial Cancer Cells 53
Th17-Gene Expression Profile in Patients with Chronic Venous Disease and Venous Ulcers: Genetic Modulations and Preliminary Clinical Evidence 52
Meccanismi genetici e molecolari della Sindrome X metabolica 51
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells. 51
SGK1 (serum/glucocorticoid regulated kinase 1) 50
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells. 50
Cascade Genetic Testing for Hereditary Cancer Predisposition: Characterization of Patients in a Catchment Area of Southern Italy 49
Germline Variant Spectrum in Southern Italian High-Risk Hereditary Breast Cancer Patients: Insights from Multi-Gene Panel Testing 48
Metabolic drives affecting Th17/Treg gene expression changes and differentiation: impact on immune‐microenvironment regulation 46
Neglected Issues in T Lymphocyte Metabolism: Purine Metabolism and Control of Nuclear Envelope Regulatory Processes. New Insights into Triggering Potential Metabolic Fragilities 45
Serum and glucocorticoid-regulated kinase Sgk1 inhibits insulin-dependent activation of phosphomannomutase 2 in transfected COS-7 cells 45
Relative Resistance of SGK1 Knockout Mice Against Chemical Carcinogenesis 43
Sgk1 promotes cell proliferation, survival and epithelial dedifferentiation by activating HDM2 dependent p53 degradation 41
The IL-23R and Its Genetic Variants: A Hitherto Unforeseen Bridge Between the Immune System and Cancer Development 40
SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition 38
The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme 36
The small molecule SI113 hinders epithelial-to-mesenchymal transition and subverts cytoskeletal organization in human cancer cells 35
RFX-1, a putative alpha Adducin interacting protein in a human kidney library 30
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells 28
Expanding the Mutational Spectrum of ACADVL: Integrative Characterization of the p.Ser72Phe Variant in Very Long-Chain Acyl-CoA Dehydrogenase Deficiency 26
The small molecule SI113 hinders epithelial-to-mesenchymal transition and subverts cytoskeletal organization in human cancer cells. 26
Cytogenetic and molecular characterization of an atypical ETP-ALL case with BCL2 dependency: therapeutic implications for Venetoclax use 20
Th17/treg balance in Inflammatory Bowel Disease: the role of microbial, and genetic regulators in disease modulation 17
Totale 3.436
Categoria #
all - tutte 26.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.703


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022136 0 0 2 39 3 12 5 16 22 17 20 0
2022/2023433 73 47 23 21 47 34 3 43 81 27 29 5
2023/2024234 38 29 11 18 15 58 2 24 5 7 14 13
2024/2025621 75 53 32 15 32 85 24 23 75 12 96 99
2025/20261.633 97 134 271 216 161 62 197 107 164 134 51 39
2026/2027243 38 96 109 0 0 0 0 0 0 0 0 0
Totale 3.436